Targeted drug release system based on pH-responsive PAA-POSS nanoparticles
Won Jung Kim1, Eu Hyun Lee1, Yong-Jin Kwon2
1Department of Fiber System Engineering, Dankook University 152, Jookjeon-ro, Suji-gu Yongin-si Gyeonggi-do 448-701 Republic of Korea.
RSC Advances
|July 8, 2022
Summary
A novel amphipathic polyacrylic acid-polyhedral oligomeric silsesquioxane (PAA-POSS) nanoparticle system effectively delivers doxorubicin chemotherapy. This pH-sensitive drug delivery system shows promise for targeted cancer therapy, demonstrated by cancer cell death.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapeutics
Background:
- The tumor microenvironment is often weakly acidic, presenting an opportunity for targeted drug delivery.
- Developing nanoparticles that respond to these pH changes can improve drug efficacy and reduce side effects.
Purpose of the Study:
- To develop an amphipathic nanoparticle system for pH-sensitive doxorubicin (DOX) delivery.
- To investigate the loading efficiency, release kinetics, and in vitro efficacy of the PAA-POSS@DOX system.
Main Methods:
- Synthesis of polyacrylic acid-polyhedral oligomeric silsesquioxane (PAA-POSS) nanoparticles.
- Loading of doxorubicin (DOX) onto the PAA-POSS nanoparticles.
- Characterization of nanoparticle size (480 ± 192 nm) and drug loading efficiency (>75%).
- In vitro assessment of DOX release under weakly acidic conditions.
- Evaluation of cytotoxicity against MDA-MB-231 breast cancer cells.
Main Results:
- Successfully synthesized amphipathic PAA-POSS nanoparticles capable of encapsulating DOX.
- Achieved high drug loading efficiency (>75%) and demonstrated rapid DOX release in response to weakly acidic pH.
- Confirmed significant cancer cell death in MDA-MB-231 cells, indicating effective targeted drug delivery.
Conclusions:
- The PAA-POSS@DOX system is a promising pH-sensitive nanoparticle for targeted cancer drug delivery.
- This system offers potential for enhanced chemotherapy efficacy by exploiting the acidic tumor microenvironment.
- Further investigation into in vivo applications is warranted.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...